BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Apple
AAPL
|
+$487M |
| 2 |
Industrial Select Sector SPDR Fund
XLI
|
+$393M |
| 3 |
Microsoft
MSFT
|
+$380M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
+$349M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$312M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
Salesforce
CRM
|
+$765M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$368M |
| 4 |
Eli Lilly
LLY
|
+$255M |
| 5 |
AGN
Allergan plc
AGN
|
+$225M |
Sector Composition
| 1 | Technology | 18.31% |
| 2 | Consumer Discretionary | 8.56% |
| 3 | Healthcare | 8.43% |
| 4 | Financials | 7.4% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1951
BioXcel Therapeutics
BTAI
$47.7M
| $118K | ﹤0.01% |
139
+8
| +6% | +$6.77K |
|
1952
Moelis & Co
MC
$5.58B
| $117K | ﹤0.01% |
3,770
-12,168
| -76% | -$379K |
|
1953
Banner Corp
BANR
$2.27B
| $117K | ﹤0.01% |
3,089
-11,630
| -79% | -$442K |
|
|
WWE
1954
DELISTED
World Wrestling Entertainment
WWE
| $117K | ﹤0.01% |
2,698
-2
| -0.1% | -$87 |
|
|
ENDP
1955
DELISTED
Endo International plc
ENDP
| $117K | ﹤0.01% |
34,153
-88,372
| -72% | -$303K |
|
|
SUM
1956
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $117K | ﹤0.01% |
7,400
-76,672
| -91% | -$1.21M |
|
|
GLOG
1957
DELISTED
GASLOG LTD
GLOG
| $116K | ﹤0.01% |
41,237
+28,703
| +229% | +$80.7K |
|
1958
Teekay
TK
$747M
| $116K | ﹤0.01% |
48,265
+26,857
| +125% | +$64.5K |
|
|
ILPT
1959
Industrial Logistics Properties Trust
ILPT
$425M
| $115K | ﹤0.01% |
5,619
-21,409
| -79% | -$440K |
|
1960
Atara Biotherapeutics
ATRA
$83.6M
| $115K | ﹤0.01% |
317
-785
| -71% | -$286K |
|
1961
Federal Signal
FSS
$7.66B
| $115K | ﹤0.01% |
3,878
-47,758
| -92% | -$1.42M |
|
1962
Artisan Partners
APAM
$3.21B
| $114K | ﹤0.01% |
3,520
-40,583
| -92% | -$1.32M |
|
|
QD
1963
Qudian
QD
$722M
| $114K | ﹤0.01% |
67,198
-385,624
| -85% | -$656K |
|
1964
Appian
APPN
$2.28B
| $114K | ﹤0.01% |
2,228
-9,643
| -81% | -$494K |
|
1965
Gentherm
THRM
$1.07B
| $114K | ﹤0.01% |
2,926
-11,193
| -79% | -$435K |
|
1966
Central Garden & Pet Class A
CENTA
$2.02B
| $114K | ﹤0.01% |
4,205
-16,988
| -80% | -$459K |
|
|
CZZ
1967
DELISTED
Cosan Limited
CZZ
| $113K | ﹤0.01% |
7,522
-27,109
| -78% | -$408K |
|
1968
Upbound Group
UPBD
$1.57B
| $113K | ﹤0.01% |
4,051
-21,770
| -84% | -$606K |
|
1969
Knowles
KN
$1.92B
| $113K | ﹤0.01% |
7,381
-144,500
| -95% | -$2.21M |
|
1970
V2X
VVX
$1.73B
| $113K | ﹤0.01% |
2,292
-3,197
| -58% | -$157K |
|
|
LMNX
1971
DELISTED
Luminex Corp
LMNX
| $112K | ﹤0.01% |
3,456
-14,279
| -81% | -$464K |
|
|
AQUA
1972
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $112K | ﹤0.01% |
6,044
-20,498
| -77% | -$381K |
|
1973
CSG Systems International
CSGS
$1.87B
| $111K | ﹤0.01% |
2,692
-12,564
| -82% | -$520K |
|
1974
Axsome Therapeutics
AXSM
$5.87B
| $111K | ﹤0.01% |
1,350
-49,334
| -97% | -$4.06M |
|
1975
Medifast
MED
$154M
| $111K | ﹤0.01% |
799
-3,872
| -83% | -$537K |
|